A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)

CompletedOBSERVATIONAL

Enrollment

189

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

May 31, 2010

Conditions

Rheumatoid Arthritis

Trial Locations (5)

Chugoku region, Chugoku

Kanto region, Kanto

Kyushu region, Kyushu

Sikoku region, Sikoku

Tohoku region, Tōhoku